Portal de investigación
Long-Term Outcome of Second Allogeneic Stem Cell Transplantation (HSCT2) for Primary Graft Failure in Patients with Acute Leukemia in Remission: A Study on Behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
Fecha de publicación:
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Nagler, Arnon
- Labopin, Myriam
- Kulagin, Alexander D.
- Velardi, Andrea
- Labussiere-Wallet, Helene
- Potter, Victoria
- Kuball, Jurgen
- Sica, Simona
- Parovichnikova, Elena N.
- Bethge, Wolfgang
- Leleu, Xavier
- Platzbecker, Uwe
- Stolzel, Friedrich
- Ciceri, Fabio
- Mohty, Mohamad
Grupos
Abstract
Abstract no disponible
Datos de la publicación
- ISSN/ISSNe:
- 0006-4971, 1528-0020
- Tipo:
- Meeting Abstract
- Páginas:
- 7578-7579
- Factor de Impacto:
- 4,834 SCImago ℠
- Cuartil:
- Q1 SCImago ℠
BLOOD ELSEVIER
Citas Recibidas en Web of Science: 1
Documentos
- No hay documentos
Filiaciones
Filiaciones no disponibles
Campos de Estudio
Cita
Nagler,A,Labopin,M,Kulagin,AD,Velardi,A,Sanz,J,Labussiere,H,Potter,V et al. Long-Term Outcome of Second Allogeneic Stem Cell Transplantation (HSCT2) for Primary Graft Failure in Patients with Acute Leukemia in Remission: A Study on Behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. 64th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH). 2022. New Orleans-LA. RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS:ELSEVIER. 2022 p.p. 7578-7579.